Vault-13

Palo Alto Investors LP

PALO ALTO, CA · CIK 1306923 · 13F filing filed 2026-08-19

SEC-registered investment adviser since 2000 · limited partnership

As an employer

$723.7m reported value +10.7% vs Q1 2026
52positions
61.3%in top 10
3 new 5 added 15 reduced 2 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PTC THERAPEUTICS INC COM PTCT PTCT 918,846 $75.0m10.36% 10.36% ReducedShares held: Q3 2025 862.6k, Q4 2025 903.9k, Q1 2026 921.6k, Q2 2026 918.8k -2.8k -2,761 -0.3%
2 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 2,864,096 $72.5m10.01% 10.01% ReducedShares held: Q3 2025 2.5m, Q4 2025 2.5m, Q1 2026 2.9m, Q2 2026 2.9m -8.6k -8,599 -0.3%
3 INSMED INC COM PAR $.01 INSM INSM 413,980 $44.1m6.10% 6.10% ReducedShares held: Q3 2025 491.8k, Q4 2025 489.5k, Q1 2026 415.3k, Q2 2026 414.0k -1.3k -1,289 -0.3%
4 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 348,808 $40.8m5.64% 5.64% AddedShares held: Q3 2025 64.7k, Q4 2025 156.4k, Q1 2026 325.2k, Q2 2026 348.8k +23.6k +23,633 7.3%
5 ANAPTYSBIO INC COM ANAB ANAB 603,489 $40.7m5.63% 5.63% ReducedShares held: Q3 2025 673.5k, Q4 2025 690.0k, Q1 2026 638.2k, Q2 2026 603.5k -34.7k -34,672 -5.4%
6 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 682,777 $39.1m5.40% 5.40% ReducedShares held: Q3 2025 754.0k, Q4 2025 746.3k, Q1 2026 685.2k, Q2 2026 682.8k -2.4k -2,405 -0.3%
7 DYNE THERAPEUTICS INC COM DYN DYN 1,647,521 $36.6m5.06% 5.06% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.5m, Q1 2026 1.7m, Q2 2026 1.6m -5.5k -5,451 -0.3%
8 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 62,587 $33.9m4.69% 4.69% ReducedShares held: Q3 2025 58.2k, Q4 2025 58.2k, Q1 2026 62.8k, Q2 2026 62.6k -222 -222 -0.3%
9 DISC MEDICINE INC COM IRON IRON 416,646 $30.5m4.21% 4.21% AddedShares held: Q3 2025 224.3k, Q4 2025 317.5k, Q1 2026 401.7k, Q2 2026 416.6k +14.9k +14,927 3.7%
10 BIOGEN INC COM BIIB BIIB 140,279 $30.3m4.19% 4.19% ReducedShares held: Q3 2025 185.7k, Q4 2025 183.6k, Q1 2026 140.7k, Q2 2026 140.3k -440 -440 -0.3%
11 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 5,296,209 $22.0m3.04% 3.04% ReducedShares held: Q3 2025 7.6m, Q4 2025 7.1m, Q1 2026 6.3m, Q2 2026 5.3m -1.1m -1,053,354 -16.6%
12 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 596,495 $19.9m2.75% 2.75% UnchangedShares held: Q3 2025 369.5k, Q4 2025 461.3k, Q1 2026 596.5k, Q2 2026 596.5k
13 NOVOCURE LTD ORD SHS NVCR NVCR 1,280,439 $19.4m2.68% 2.68% UnchangedShares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.3m
14 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 864,986 $18.9m2.61% 2.61% UnchangedShares held: Q3 2025 654.9k, Q4 2025 794.5k, Q1 2026 865.0k, Q2 2026 865.0k
15 ANNEXON INC COM ANNX ANNX 2,948,090 $16.8m2.33% 2.33% UnchangedShares held: Q3 2025 0, Q4 2025 2.4m, Q1 2026 2.9m, Q2 2026 2.9m
16 BICARA THERAPEUTICS INC COM BCAX BCAX 550,408 $16.3m2.26% 2.26% UnchangedShares held: Q3 2025 0, Q4 2025 298.6k, Q1 2026 550.4k, Q2 2026 550.4k
17 CAREDX INC COM CDNA CDNA 531,870 $15.2m2.09% 2.09% UnchangedShares held: Q3 2025 316.2k, Q4 2025 478.2k, Q1 2026 531.9k, Q2 2026 531.9k
18 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 399,856 $14.9m2.06% 2.06% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 296.4k, Q2 2026 399.9k +103.4k +103,448 34.9%
19 COMPASS THERAPEUTICS INC COM CMPX CMPX 5,831,813 $12.8m1.76% 1.76% AddedShares held: Q3 2025 0, Q4 2025 2.5m, Q1 2026 1.5m, Q2 2026 5.8m +4.3m +4,317,309 285.1%
20 ALKERMES PLC SHS ALKS ALKS 242,560 $12.7m1.76% 1.76% UnchangedShares held: Q3 2025 183.9k, Q4 2025 242.6k, Q1 2026 242.6k, Q2 2026 242.6k
21 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 603,489 $12.1m1.68% 1.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 603.5k
22 PROTHENA CORP PLC SHS PRTA PRTA 1,143,155 $11.2m1.55% 1.55% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.2m, Q2 2026 1.1m -65.4k -65,413 -5.4%
23 TRAVERE THERAPEUTICS INC COM TVTX TVTX 167,525 $9.5m1.32% 1.32% ReducedShares held: Q3 2025 110.7k, Q4 2025 110.7k, Q1 2026 230.5k, Q2 2026 167.5k -62.9k -62,928 -27.3%
24 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 1,391,382 $9.5m1.31% 1.31% UnchangedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.4m, Q2 2026 1.4m
25 ACLARIS THERAPEUTICS INC COM ACRS ACRS 1,613,430 $8.5m1.18% 1.18% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.6m, Q2 2026 1.6m
26 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 213,601 $7.9m1.10% 1.10% UnchangedShares held: Q3 2025 265.5k, Q4 2025 212.5k, Q1 2026 213.6k, Q2 2026 213.6k
27 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 229,763 $5.5m0.76% 0.76% UnchangedShares held: Q3 2025 0, Q4 2025 226.3k, Q1 2026 229.8k, Q2 2026 229.8k
28 ALIGN TECHNOLOGY INC COM ALGN ALGN 31,389 $5.3m0.73% 0.73% ReducedShares held: Q3 2025 45.7k, Q4 2025 41.5k, Q1 2026 41.5k, Q2 2026 31.4k -10.1k -10,131 -24.4%
29 ORUKA THERAPEUTICS INC COM ORKA ORKA 33,546 $3.2m0.44% 0.44% ReducedShares held: Q3 2025 60.0k, Q4 2025 60.0k, Q1 2026 60.0k, Q2 2026 33.5k -26.4k -26,439 -44.1%
30 XENON PHARMACEUTICALS INC COM XENE XENE 51,345 $3.1m0.43% 0.43% UnchangedShares held: Q3 2025 0, Q4 2025 96.5k, Q1 2026 51.3k, Q2 2026 51.3k
31 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 18,117 $3.1m0.42% 0.42% UnchangedShares held: Q3 2025 18.1k, Q4 2025 18.1k, Q1 2026 18.1k, Q2 2026 18.1k
32 EDWARDS LIFESCIENCES CORP COM EW EW 33,640 $3.0m0.42% 0.42% UnchangedShares held: Q3 2025 33.6k, Q4 2025 33.6k, Q1 2026 33.6k, Q2 2026 33.6k
33 STOKE THERAPEUTICS INC COM STOK STOK 84,631 $2.8m0.38% 0.38% UnchangedShares held: Q3 2025 105.4k, Q4 2025 72.0k, Q1 2026 84.6k, Q2 2026 84.6k
34 CYTOKINETICS INC COM NEW CYTK CYTK 32,195 $2.7m0.38% 0.38% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 32.2k, Q2 2026 32.2k
35 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 864,277 $2.6m0.36% 0.36% ReducedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 1.0m, Q2 2026 864.3k -146.2k -146,233 -14.5%
36 EHEALTH INC COM EHTH EHTH 1,482,797 $2.2m0.31% 0.31% UnchangedShares held: Q3 2025 1.5m, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m
37 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 39,605 $2.2m0.30% 0.30% UnchangedShares held: Q3 2025 41.2k, Q4 2025 41.2k, Q1 2026 39.6k, Q2 2026 39.6k
38 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 250,000 $1.9m0.27% 0.27% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
39 NUVATION BIO INC COM CL A NUVB NUVB 326,609 $1.9m0.26% 0.26% ReducedShares held: Q3 2025 1.0m, Q4 2025 538.1k, Q1 2026 508.8k, Q2 2026 326.6k -182.2k -182,237 -35.8%
40 BIONTECH SE SPONSORED ADS BNTX BNTX 19,614 $1.8m0.25% 0.25% UnchangedShares held: Q3 2025 19.6k, Q4 2025 19.6k, Q1 2026 19.6k, Q2 2026 19.6k
41 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 115,616 $1.6m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 115.6k, Q1 2026 115.6k, Q2 2026 115.6k
42 HUMANA INC COM HUM HUM 3,985 $1.6m0.22% 0.22% UnchangedShares held: Q3 2025 4.0k, Q4 2025 4.0k, Q1 2026 4.0k, Q2 2026 4.0k
43 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 44,359 $1.5m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 44.4k
44 VERASTEM INC COM NEW VSTM VSTM 309,685 $1.2m0.16% 0.16% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 246.1k, Q2 2026 309.7k +63.6k +63,592 25.8%
45 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 1,787 $959.5k0.13% 0.13% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.8k, Q2 2026 1.8k
46 UROGEN PHARMA LTD COM URGN URGN 24,500 $901.6k0.12% 0.12% UnchangedShares held: Q3 2025 24.5k, Q4 2025 24.5k, Q1 2026 24.5k, Q2 2026 24.5k
47 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 201,890 $856.0k0.12% 0.12% UnchangedShares held: Q3 2025 221.1k, Q4 2025 221.1k, Q1 2026 201.9k, Q2 2026 201.9k
48 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 104,410 $826.9k0.11% 0.11% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 104.4k, Q2 2026 104.4k
49 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 108,865 $672.8k0.09% 0.09% UnchangedShares held: Q3 2025 108.9k, Q4 2025 108.9k, Q1 2026 108.9k, Q2 2026 108.9k
50 INSPIRE MED SYS INC COM INSP INSP 8,772 $391.3k0.05% 0.05% UnchangedShares held: Q3 2025 0, Q4 2025 8.8k, Q1 2026 8.8k, Q2 2026 8.8k
51 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 188,807 $351.2k0.05% 0.05% UnchangedShares held: Q3 2025 188.8k, Q4 2025 188.8k, Q1 2026 188.8k, Q2 2026 188.8k
52 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 155,709 $331.7k0.05% 0.05% UnchangedShares held: Q3 2025 225.5k, Q4 2025 225.5k, Q1 2026 155.7k, Q2 2026 155.7k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
AMICUS THERAPEUTICS INC FOLD FOLD 1,113,045 $16.1m1.1m shares
DENALI THERAPEUTICS INC DNLI DNLI 234,582 $4.5m234.6k shares